ASCO Data Shows New Therapy Keeps Myeloma Patients in Remission for 5+ Years. Here's what you need to know about the ...

The results feed into an effort to identify to monoclonal antibody combinations that would prevent and possibly treat HIV ...

First-in-human data for the trispecific antibody “suggest a paradigm shift” for the relapsed/refractory multiple myeloma ...

A grandad diagnosed with stage 4 lung cancer–one of the deadliest—has become disease-free after being treated with an ...

Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, ...

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing ...

AI can help identify women who might be helped by cancer therapies that target HER2, a protein that spurs on the growth of ...

Chinese doctors have reported a milestone in domestically made innovative medicine, announcing that a combination of ...

Summit Therapeutics (SMMT) stock rises as its lung cancer drug ivonescimab with chemotherapy hit the main goal in a Phase 3 ...